Trial Profile
A randomised,placebo controlled study to evaluate the efficacy and safety of Ezetimibe on pregressive stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 26 Apr 2017 New trial record